ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 191 filers reported holding ARGENX SE in Q1 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,962,243 | +404.0% | 73,149 | +282.0% | 0.18% | +405.7% |
| Q1 2023 | $7,134,907 | +15.3% | 19,150 | +17.3% | 0.04% | +2.9% |
| Q4 2022 | $6,186,294 | +2977.8% | 16,330 | +2133.9% | 0.03% | +3300.0% |
| Q1 2021 | $201,000 | -98.2% | 731 | -98.3% | 0.00% | -98.9% |
| Q3 2020 | $11,216,000 | +160.1% | 42,724 | +123.1% | 0.09% | +89.8% |
| Q2 2020 | $4,312,000 | +823.3% | 19,147 | +439.7% | 0.05% | +276.9% |
| Q1 2020 | $467,000 | -90.9% | 3,548 | -88.9% | 0.01% | -87.0% |
| Q4 2019 | $5,138,000 | +90.9% | 32,011 | +35.5% | 0.10% | +112.8% |
| Q3 2019 | $2,692,000 | +599.2% | 23,619 | +769.0% | 0.05% | +327.3% |
| Q2 2019 | $385,000 | -73.8% | 2,718 | -76.9% | 0.01% | -75.0% |
| Q1 2019 | $1,467,000 | – | 11,753 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |